Protein Quantification Using Resonance Energy Transfer between Donor Nanoparticles and Acceptor Quantum Dots

Abstract

A homogeneous time-resolved luminescence resonance energy transfer (TR-LRET) assay has been developed to quantify proteins. The competitive assay is based on resonance energy transfer (RET) between two luminescent nanosized particles. Polystyrene nanoparticles loaded with Eu(3+) chelates (EuNPs) act as donors, while protein-coated quantum dots (QDs), either CdSe/ZnS emitting at 655 nm (QD655-strep) or CdSeTe/ZnS with emission wavelength at 705 nm (QD705-strep), are acceptors. In the absence of analyte protein, in our case bovine serum albumin (BSA), the protein-coated QDs bind nonspecifically to the EuNPs, leading to RET. In the presence of analyte proteins, the binding of the QDs to the EuNPs is prevented and the RET signal decreases. RET from the EuNPs to the QDs was confirmed and characterized with steady-state and time-resolved luminescence spectroscopy. In accordance with the Förster theory, the approximate average donor-acceptor distance is around 15 nm at RET efficiencies, equal to 15% for QD655 and 13% for QD705 acceptor, respectively. The limits of detection are below 10 ng of BSA with less than a 10% average coefficient of variation. The assay sensitivity is improved, when compared to the most sensitive commercial methods. The presented mix-and-measure method has potential to be implemented into routine protein quantification in biological laboratories.

Nanomaterials-Based Fluorimetric Methods for MicroRNAs Detection

“…Quantum dots (QDs) are novel semiconductor nanocrystals with unique optical properties, including size-tunable photoluminescence spectra and relatively high quantum yield, and have been widely used as fluorescent markers in biological labeling, fluorescence imaging, and drug delivery [38,39,40,41]. In particular, QDs hold great promise as fluorescence resonance energy transfer (FRET) donors in the biosensing applications to homogeneously detect nucleic acids, proteins, and small molecules [42].…”

Photophysical evaluation of a new functional terbium complex in FRET-based time-resolved homogenous fluoroassays

“…The DCM has already proven its potential in multiplexed lung cancer assays 33 and protein concentration assays. 6 The method allows enhancing signal-to-background ratio. Therefore, very small changes in FRET signal can be extracted from luminescence decays with improved precision and, consequently, lower LODs can be achieved.…”

“…Their potential has already been demonstrated in drug screening assays, 1 luminescent cellular imaging, 2 homogenous 3 and heterogeneous 4 immunoassays, FRET fluoroassays 5 or in bioassays to determine protein concentration. 6 Typically, an LLC contains an organic chelate, central lanthanide ion, and optionally, a molecular spacer terminated with a functional group. The organic chelate acts as an ''antenna'' that first harvests and then transfers light to the central lanthanide ion (Fig.…”

Ultrafast FRET at fiber tips: Potential applications in sensitive remote sensing of molecular interaction

“…However, validation of FRET and consequent use of the formulism for the estimation of the molecular distance between the donor and the acceptor demands a careful analysis of the excited state lifetime of the fluorophores with picosecond resolution [12]. In some of the recent studies the usefulness of the picosecond resolved fluorescence measurement for the FRET based sensor (not using an optical fiber) has been recognized [13][14][15]. In a report using quantum dots linked to DNA have been used in an ultrasensitive nanosensor based on fluorescence resonance energy transfer (FRET) capable of detecting low concentrations of DNA in a separation-free format [13].…”

“…Another study demonstrated that fluorescence lifetime data accurately be recorded via miniature fiber endoscopes that can discriminate dichotomous labeled structures and cells [14]. In a recent study FRET between donor nanoparticle and acceptor quantum dots is utilized in protein quantification [15].…”